Biotech Business Week

Gout - New drug application submitted for Oxyprim

HIV Testing - Uni-Gold Recombigen HIV test receives FDA approval

Heart Disease - Primary endpoints met in phase I/II clinical trial of DX-88

Heart Failure - Triage B-type natriuretic peptide test approved for use on Beckman Coulter platforms

Hepatitis Virus - Antiseptic hand spray formula proven to kill hepatitis A, B and C viruses

Hypertension - Remodulin receives preliminary notice of approval in Switzerland and Australia

Influenza - BCBSNC gives North Carolina Health Departments $300,000 for flu vaccines

Inhaled Insulin - Human trials of Alveair insulin pulmonary technology about to begin

Leg Ulcers - Premarket approval application to be filed for venous leg ulcer treatment

Tumor Growth - Small molecule shown to inhibit tumor growth in preclinical models

Legal Issues - Biotech patent dispute settled

Medical Technology - Global healthcare technology company chooses parts management company

Meningococcal Meningitis - BLA submitted for approval of Menactra

Mergers and Acquisitions - Biopharmaceutical service company acquired

Mergers and Acquisitions - Drug discovery companies announce merger

Mergers and Acquisitions - European pharmaceutical sales, marketing business sold for $120M

Mergers and Acquisitions - Express Scripts, CuraScript announce acquisition agreement

Mergers and Acquisitions - Implant product manufacturer announces termination of acquisition negotiations

Mergers and Acquisitions - Pharmaceutical firms receive FTC request for information on transactions

Multiple Myeloma - Breakthrough discovery puts researchers closer to cure for multiple myeloma

AIDS Therapy - DSMB recommends continuation of phase I trial with VRX496 modified T cells

Multiple Myeloma - Thalidomide Pharmion approved in New Zealand

Myelodysplastic Syndrome - Enrollment stopped for myelodysplastic syndromes monotherapy trial

Myelodysplastic Syndrome - New drug application submitted to market myelodysplastic syndromes therapy

Myocardial Infarction - Company seeks new drug indication for treatment of heart attack survivors

Personnel - Biotech firm appoints renowned biochemist to scientific advisory board

Personnel - Cardiovascular drug development company announces election of directors

Personnel - Chief financial officer resigns from biotech firm

Personnel - Pain management company announces executive appointments

Personnel - Pharmaceutical company announces new chief business officer

Personnel - Pharmaceutical company founder and chairman steps down to nonexecutive role

Acne - New drug application submitted for Actiza

Personnel - Rosa named VP, strategic development at molecular fingerprinting company

Personnel - Silverstein joins board of directors at pharmaceutical company

Personnel - Therapeutics company announces management changes, promotions

Personnel - Two new board members named at drug delivery company

Podiatric Surgery - Study shows reduced pain and narcotic use following foot and ankle surgery

Prostate Cancer - Cancer vaccine manufacturer obtains rights to Biogen Idec LFA-3 patents

Prosthetics - Hydraulic knee frame reintroduced to market

Psoriasis - PVAC program is discontinued due to lack of clinical benefit

Restenosis - Positive phase II clinical results reported in trial of Resten-NG

Rosacea - Finacea 15% gel approved in E.U. countries

Angina - U.S. Food and Drug Administration advisory committee evaluates Ranexa

Urinary Tract Infections - Phase III trial begins with Doripenem in complicated urinary tract infections

Vaccines - Investigational new drug application to be filed for HIV vaccine

Venous Thromboembolism - New drug application submitted to FDA for Exanta